Identification of the most active interleukin-32 isoform.
about
Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 productionImportant Role of the IL-32 Inflammatory Network in the Host Response against Viral InfectionInterleukin-32 expression in the pancreasInterleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.Interleukin-32 in inflammatory autoimmune diseases.IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells.The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infectionIL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.Caspase-3-independent apoptotic pathways contribute to interleukin-32γ-mediated control of Mycobacterium tuberculosis infection in THP-1 cellsIL-32γ delays spontaneous apoptosis of human neutrophils through MCL-1, regulated primarily by the p38 MAPK pathway.IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.Association between IL-32 genotypes and outcome in infection-associated acute lung injury.Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polypsDifferential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway BlockadeSoluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst.DNA methylation at IL32 in juvenile idiopathic arthritis.Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alphaCytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species.IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production.Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32β overexpressed transgenic mice.Association of Plasma IL-32 Levels and Gene Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population.Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin.Mycobacterium tuberculosis PPE32 promotes cytokines production and host cell apoptosis through caspase cascade accompanying with enhanced ER stress response.Novel insights into the biology of interleukin-32.IL-32α-induced inflammation constitutes a link between obesity and colon cancer.A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation.Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma.TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human corneaRole of interleukin-32 in Helicobacter pylori-induced gastric inflammation.Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients.Interleukin-32 promotes lipid accumulation through inhibition of cholesterol efflux.Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function.
P2860
Q24317887-92A28D42-28E3-465F-B018-643685D81762Q26826958-D6F08D2B-E8FD-446D-8195-A39BBE214405Q28390023-00C17F6F-362F-4C43-BB36-D656C5A5112AQ33633481-F1D06D53-1AC1-447B-9EEA-B7F3D8CF4237Q33838804-DE2F4FE5-6EC3-4A23-BB04-C67A587D82D8Q33909932-4EB2DB5B-D965-4E8E-ABE9-8555C4095BE4Q34396945-F81E0E3A-A5B2-42FC-87F7-9C167856A217Q34720467-4AF23291-1D41-4E7D-AC05-CDE303A49BFAQ34752043-2FE787F8-77F3-45D2-8DD6-0EFE3BDFE942Q34995534-CD10E95C-F43C-486C-B786-05B0E1D0705FQ35134651-F6020146-0287-4C13-84C3-C2C640DD7C45Q35147724-0F528EB4-35E8-4455-AC72-91074F7B4090Q35294123-EA177007-BD13-40C2-A947-F697AE7B95C3Q35469357-80141098-CBB8-456E-836A-CF628AB43BFEQ35549372-9811C149-1D33-42F8-B512-F68E47AA6F45Q35552026-C2E0DD82-0A33-478F-979E-860D240A4166Q35558297-A96EDAB2-AD16-4891-92FE-36F28B9E9E88Q35605921-038FF35B-146F-4A1B-9249-0E30BB359513Q36021317-488D842F-4A99-4062-A6EE-451332965E42Q36085075-BB226BCF-6D52-48AB-8BB5-3F943E53C0F9Q36156306-E8FBBCDF-DB17-4706-A677-B7CC534704BAQ36246023-C25BBF85-5E52-4978-B56D-CB04A18A94E2Q36291428-29D0CF1B-3660-4D33-BAC1-9A158ECB10ADQ36562157-9AE65FD9-B336-4F00-AF82-07C67680D808Q36629365-B087D9EA-E467-47AE-BEBB-AECCC09B555FQ36680867-F75F093A-678A-4EAC-A21D-DA6F40975DCCQ36687921-0CA5C521-7279-41F8-94AD-BCAE8BF5DE70Q37584726-EC6F1811-A4EE-4B76-BEF3-C8B4B1EB3C58Q37662318-FA6B9A37-473E-47E8-ABF9-2479E69EC801Q37687168-F4235FE2-9866-4992-8E20-5133B8200DE0Q38086768-44BB47A9-E3BF-4709-973A-896C88D47DBBQ38287509-43195F10-C1C6-44E3-94B1-9788E58959F6Q38334454-F95C6A76-D17C-4A5B-9702-7210F83C40F2Q38443719-28558BDD-44FE-4F50-9516-151C894B52C8Q38901833-5E037331-2ED1-448F-B37B-DADF45B09A6FQ39297849-AD28CBC2-FA37-4392-9FAC-0C74622A91DCQ39611935-BA92EC7E-0E0C-40DA-A38C-D31A3F040377Q40216038-45C250C3-0CE2-4D88-879A-5AD6C050264FQ41116795-28731B21-E0CA-4295-B8BC-4D9CB9A06272Q41262546-CFF36B03-92B5-4C28-B6AB-0768A75353C2
P2860
Identification of the most active interleukin-32 isoform.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Identification of the most active interleukin-32 isoform.
@en
Identification of the most active interleukin-32 isoform.
@nl
type
label
Identification of the most active interleukin-32 isoform.
@en
Identification of the most active interleukin-32 isoform.
@nl
prefLabel
Identification of the most active interleukin-32 isoform.
@en
Identification of the most active interleukin-32 isoform.
@nl
P2093
P2860
P1433
P1476
Identification of the most active interleukin-32 isoform.
@en
P2093
Bo-Kyung Kim
Chang-Kwon Lee
Do-Young Yoon
Jae-Woo Hong
Ji-Da Choi
Soo-Hyun Kim
Su-Young Bae
Sun-Jong Kim
Tania Azam
P2860
P304
P356
10.1111/J.1365-2567.2008.02917.X
P577
2008-09-02T00:00:00Z